Ensurge Delivers First Shipment of Solid-State Lithium Microbatteries to Leading Medical Device Company
27 Junio 2024 - 1:00AM
UK Regulatory
Ensurge Delivers First Shipment of Solid-State Lithium
Microbatteries to Leading Medical Device Company
OSLO, Norway, 27 June, 2024 -- Ensurge Micropower
(OSE: ENSU, and OTCQB: ENMPY) ("Ensurge" or the "Company"), today
announces it has delivered samples of its solid-state lithium
microbattery to a customer within the medical-device industry. This
shipment is in accordance with an evaluation agreement that was
signed and announced on 25 October, 2023.
“This is our first shipment to this Fortune 500
medical device manufacturer for initial feasibility testing of
integrating Ensurge 10um battery technology into various future
applications.” said Lars Eikeland, CEO at Ensurge.
Testing to date shows that Ensurge`s microbattery
delivers faster charging, longer cycle life, and greater safety
than any other microbatteries, in addition to its extremely
valuable benefits of customizable form factors and compatibility
with widely adopted Surface Mount Technology (SMT) assembly
processes.
About Ensurge Micropower
Ensurge is Energizing Innovation™ with the first ultrathin,
flexible, reliable, and fundamentally safe solid-state lithium
microbattery for the 1 to 100 milliampere-hour (mAh) class of
wearable devices, connected sensors, and beyond. The innovative
Ensurge Microbattery enables energy-dense rechargeable products
that are ideal for form-factor-constrained applications including
hearables (hearing aids and wireless headphones), digital and
health wearables, sports and fitness devices, and IoT sensor
solutions that use energy harvesting to power everyday things. The
company's state-of-the-art manufacturing facility, located in the
heart of Silicon Valley, combines patented process technology and
materials innovation with the scale of roll-to-roll production
methods to bring the advantages of Ensurge technology to
established and expanding markets.
This information is subject of the disclosure
requirements pursuant to section 5-12 of the Norwegian Securities
Trading Act.
Contact
Investor Relations
E-mail: IR@ensurge.com
Lars Eikeland, CEO at Ensurge
E-mail: lars.eikeland@ensurge.com
Ensurge Micropower Asa (LSE:0JI9)
Gráfica de Acción Histórica
De Feb 2025 a Mar 2025
Ensurge Micropower Asa (LSE:0JI9)
Gráfica de Acción Histórica
De Mar 2024 a Mar 2025